Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diarylheptanoids | 1 | 2024 | 1 | 0.890 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2026 | 166 | 0.860 |
Why?
|
| Interleukin-6 | 1 | 2023 | 198 | 0.700 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 686 | 0.670 |
Why?
|
| Molecular Structure | 2 | 2024 | 245 | 0.390 |
Why?
|
| Cell Proliferation | 2 | 2024 | 825 | 0.330 |
Why?
|
| Molecular Docking Simulation | 3 | 2026 | 53 | 0.310 |
Why?
|
| Dihydropteroate Synthase | 1 | 2026 | 2 | 0.250 |
Why?
|
| Structure-Activity Relationship | 2 | 2024 | 209 | 0.240 |
Why?
|
| Drug Design | 2 | 2024 | 63 | 0.240 |
Why?
|
| Drug Discovery | 1 | 2026 | 37 | 0.240 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2026 | 45 | 0.240 |
Why?
|
| Alpinia | 1 | 2024 | 1 | 0.220 |
Why?
|
| Alkylation | 1 | 2024 | 18 | 0.220 |
Why?
|
| Stereoisomerism | 1 | 2024 | 45 | 0.220 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2024 | 5 | 0.220 |
Why?
|
| Computer-Aided Design | 1 | 2024 | 14 | 0.220 |
Why?
|
| Light | 1 | 2024 | 118 | 0.210 |
Why?
|
| Biological Products | 1 | 2024 | 67 | 0.210 |
Why?
|
| Indoles | 1 | 2024 | 111 | 0.200 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 133 | 0.200 |
Why?
|
| Carbohydrates | 1 | 2023 | 17 | 0.200 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2023 | 103 | 0.190 |
Why?
|
| Boron Compounds | 1 | 2022 | 5 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 167 | 0.190 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2022 | 18 | 0.190 |
Why?
|
| Rats | 1 | 2026 | 1588 | 0.190 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 1351 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 536 | 0.180 |
Why?
|
| Humans | 6 | 2026 | 28884 | 0.140 |
Why?
|
| Animals | 4 | 2026 | 10699 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2023 | 1469 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 31 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 22 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2010 | 55 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 285 | 0.070 |
Why?
|
| Pterins | 1 | 2026 | 2 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2026 | 58 | 0.060 |
Why?
|
| Binding Sites | 1 | 2026 | 355 | 0.060 |
Why?
|
| Hepatoblastoma | 1 | 2024 | 6 | 0.060 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2024 | 2 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2024 | 2 | 0.050 |
Why?
|
| Spiro Compounds | 1 | 2024 | 5 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2024 | 47 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2024 | 332 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 275 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2022 | 80 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2022 | 50 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2024 | 523 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 4808 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2010 | 60 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 60 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 57 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 62 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 292 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1022 | 0.020 |
Why?
|